Cargando…
Drug Interactions between Antimicrobial and Immunosuppressive Agents in Solid Organ Transplant Recipients
The number of allogeneic solid organ and bone marrow transplants is increasing all over the world. To prevent transplant rejection and treat acute rejection of transplant, immunosuppressant drugs are used. The outcomes of solid organ transplants have dramatically improved over last 30 years, due to...
Autores principales: | Bhagat, Vikas, Pandit, Rahul A, Ambapurkar, Shwetha, Sengar, Manju, Kulkarni, Atul P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874296/ https://www.ncbi.nlm.nih.gov/pubmed/33603305 http://dx.doi.org/10.5005/jp-journals-10071-23439 |
Ejemplares similares
-
COVID-19 Hospitalization in Solid Organ Transplant Recipients on Immunosuppressive Therapy
por: Kolla, Epiphane, et al.
Publicado: (2023) -
Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients
por: Merli, Marco, et al.
Publicado: (2021) -
The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients
por: O'Leary, Jacqueline G., et al.
Publicado: (2016) -
Antimicrobial stewardship programs in solid‐organ transplant recipients in Switzerland
por: Bielicki, Julia A., et al.
Publicado: (2022) -
Elevated Incidence of Fractures in Solid-Organ Transplant Recipients on Glucocorticoid-Sparing Immunosuppressive Regimens
por: Edwards, B. J., et al.
Publicado: (2011)